Alvotech (ALVO) Total Non-Current Liabilities (2020 - 2026)
Alvotech's (ALVO) quarterly Total Non-Current Liabilities came in at $1.4 billion in Q1 2026, little changed YoY from $1.4 billion in Q1 2025, and down 1.62% on a QoQ basis from $1.5 billion in Q4 2025.
Alvotech (ALVO) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has 7 years of Total Non-Current Liabilities data on file, last reported at $1.4 billion in Q1 2026.
- Quarterly Total Non-Current Liabilities changed 0.2% year-over-year to $1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (changed 0.2% YoY) and the FY2025 annual result came in at $1.5 billion, up 1.86% from the prior year.
- Total Non-Current Liabilities declined to $1.4 billion in Q1 2026, from $1.5 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $1.6 billion in Q4 2023 to a low of $471.9 million in Q2 2024.
- A 5-year average of $1.3 billion and a median of $1.4 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities sank 59.58% — and 2025, when it soared 172.57%.
- Tracing ALVO's Total Non-Current Liabilities over 5 years: stood at $1.2 billion in 2022, then soared by 32.32% to $1.6 billion in 2023, then fell by 11.15% to $1.4 billion in 2024, then climbed by 1.86% to $1.5 billion in 2025, then slipped by 1.62% to $1.4 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $1.4 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -13.28 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 16.45 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.64 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 33.50 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.76 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.37 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.42 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 334.00 Mn |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn | 1.44 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.44 Bn |
| Dec 31, 2025 | 1.47 Bn |
| Sep 30, 2025 | 1.44 Bn |
| Jun 30, 2025 | 1.29 Bn |
| Mar 31, 2025 | 1.44 Bn |
| Dec 31, 2024 | 1.44 Bn |
| Sep 30, 2024 | 1.42 Bn |
| Jun 30, 2024 | 471.93 Mn |
| Mar 31, 2024 | 1.47 Bn |
| Dec 31, 2023 | 1.62 Bn |
| Jun 30, 2023 | 1.17 Bn |
| Mar 31, 2023 | 1.39 Bn |
| Dec 31, 2022 | 1.23 Bn |
| Jun 30, 2022 | 792.93 Mn |
| Dec 31, 2021 | 621.75 Mn |
| Dec 31, 2020 | 1.29 Bn |